Kent-Athlone Pharma Group has successfully divested Athlone Laboratories, an Irish manufacturer of oral antibiotics, to Gaelic Laboratories to streamline operations and expand market reach.

Information on the Target

Kent-Athlone Pharma Group has acted as the exclusive financial advisor in the sale of Athlone Laboratories, an esteemed Irish manufacturer specializing in oral antibiotic finished dosage forms (FDFs). Athlone Laboratories, a subsidiary of Linnum Holdings and part of the Kent-Athlone Pharma Group, is recognized for its production of semi-synthetic penicillins (SSPs) and focuses on critical oral antibiotic formulations, such as amoxicillin capsules, powders for oral suspension, and flucloxacillin capsules.

With a robust client base, Athlone Laboratories serves customers across Ireland, the United Kingdom, and various European countries including the Netherlands, Belgium, and Germany, as well as other international markets. Post-sale, Kent-Athlone Pharma Group will continue to market and manage the distribution of products manufactured by Athlone Laboratories, which now falls under Gaelic Laboratories.

Industry Overview in Ireland

The healthcare and pharmaceuticals sector in Ireland is robust and is recognized as a significant contributor to the country's economy. Ireland is home to many multinational pharmaceutical companies, making it a pivotal hub